Molecular and clinical advances in anticancer drug resistance:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boston u.a.
Kluwer
1991
|
| Schriftenreihe: | Cancer treatment and research
57 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XII, 308 S. Ill., graph. Darst. |
| ISBN: | 0792312120 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV007693362 | ||
| 003 | DE-604 | ||
| 005 | 19941104 | ||
| 007 | t | ||
| 008 | 930421s1991 ad|| |||| 00||| eng d | ||
| 020 | |a 0792312120 |9 0-7923-1212-0 | ||
| 035 | |a (OCoLC)23287814 | ||
| 035 | |a (DE-599)BVBBV007693362 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 |a DE-188 | ||
| 050 | 0 | |a RC271.C5 | |
| 082 | 0 | |a 616.99/4061 |2 20 | |
| 084 | |a XD 2089 |0 (DE-625)152541:12998 |2 rvk | ||
| 245 | 1 | 0 | |a Molecular and clinical advances in anticancer drug resistance |c ed. by Robert F. Ozols |
| 264 | 1 | |a Boston u.a. |b Kluwer |c 1991 | |
| 300 | |a XII, 308 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Cancer treatment and research |v 57 | |
| 500 | |a Literaturangaben | ||
| 650 | 4 | |a Alkylating Agents |x pharmacology | |
| 650 | 4 | |a Doxorubicin |x pharmacology | |
| 650 | 4 | |a Drug Resistance |x genetics | |
| 650 | 4 | |a Drug resistance in cancer cells | |
| 650 | 4 | |a Membrane Glycoproteins |x genetics | |
| 650 | 4 | |a Neoplasms |x drug therapy | |
| 650 | 4 | |a Vinblastine |x pharmacology | |
| 650 | 0 | 7 | |a Krebszelle |0 (DE-588)4128704-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |D s |
| 689 | 1 | 1 | |a Krebszelle |0 (DE-588)4128704-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 2 | 1 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 2 | 2 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Ozols, Robert F. |e Sonstige |4 oth | |
| 830 | 0 | |a Cancer treatment and research |v 57 |w (DE-604)BV000001082 |9 57 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005049978&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005049978 | ||
Datensatz im Suchindex
| _version_ | 1804122053897355264 |
|---|---|
| adam_text | MOLECULAR AND CLINICAL ADVANCES IN ANTICANCER DRUG RESISTANCE EDITED BY
ROBERT F. OZOLS FOX CHASE CANCER CENTER 1991 KLUWER ACADEMIC PUBLISHERS
BOSTON / DORDRECHT / LONDON TABLE OF CONTENTS FOREWORD TO THE SERIES VII
LIST OF CONTRIBUTORS IX PREFACE XI 1. NEW MECHANISMS OF GENE
AMPLIFICATION IN DRUG RESISTANCE (THE EPISOME MODEL) 1 DANIEL D. VON
HOFF 2. DNA-DAMAGE INDUCIBLE GENES 13 MATILDA A. PAPATHANASIOU AND
ALBERT J. FORNACE, JR. 3. MOLECULAR BIOLOGY OF P-GLYCOPROTEIN 37 MARILYN
M. CORNWELL 4. RESISTANCE TO INHIBITORS OF DNA TOPOISOMERASES 57 DANIEL
M. SULLIVAN AND WARREN E. ROSS 5. EXPRESSION OF THE MDR1 GENE IN HUMAN
CANCERS 101 LORI J. GOLDSTEIN, MICHAEL M. GOTTESMAN, AND IRA PASTAN 6.
IMMUNOBLOT DETECTION OF P-GLYCOPROTEIN IN HUMAN TUMORS AND CELL LINES .:
121 WILLIAM J. FREDERICKS, YANFENG CHEN, AND RAYMOND M. BAKER 7.
MODULATORS OF P-GLYCOPROTEIN-ASSOCIATED MULTIDRUG RESISTANCE ... 151
WILLIAM T. BECK 8. CLINICAL IMPLICATIONS OF MULTIDRUG RESISTANCE TO
CHEMOTHERAPY.... 171 E.G.E. DE VRIES AND H.M. PINEDO V 9. THE ROLE OF
P-GLYCOPROTEIN IN DRUG-RESISTANT HEMATOLOGIC MALIGNANCIES 187 WILLIAM S.
DALTON, THOMAS M. GROGAN, AND THOMAS P. MILLER 10. DNA REPAIR IN DRUG
RESISTANCE: STUDIES ON THE REPAIR PROCESS AT THE LEVEL OF THE GENE 209
CHARLES J. LINK JR. AND VILHELM A. BOHR 11. MECHANISMS OF RESISTANCE TO
CISPLATIN 233 ALAN EASTMAN 12. THE ROLE OF METALLOTHIONEINS IN
ANTICANCER DRUG RESISTANCE 251 ROBERT R. BAHNSON, ALAKANANDA BASU, AND
JOHN S. LAZO 13. MODULATION OF ANTITUMOR ALKYLATING AGENTS (AA) 261
BEVERLY A. TEICHER AND EMIL FREI III INDEX 297 VI
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV007693362 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 |
| callnumber-search | RC271.C5 |
| callnumber-sort | RC 3271 C5 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XD 2089 |
| ctrlnum | (OCoLC)23287814 (DE-599)BVBBV007693362 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02421nam a2200613 cb4500</leader><controlfield tag="001">BV007693362</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19941104 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1991 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0792312120</subfield><subfield code="9">0-7923-1212-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)23287814</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007693362</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 2089</subfield><subfield code="0">(DE-625)152541:12998</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular and clinical advances in anticancer drug resistance</subfield><subfield code="c">ed. by Robert F. Ozols</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston u.a.</subfield><subfield code="b">Kluwer</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 308 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer treatment and research</subfield><subfield code="v">57</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alkylating Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Doxorubicin</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance</subfield><subfield code="x">genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug resistance in cancer cells</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Membrane Glycoproteins</subfield><subfield code="x">genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vinblastine</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebszelle</subfield><subfield code="0">(DE-588)4128704-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Krebszelle</subfield><subfield code="0">(DE-588)4128704-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ozols, Robert F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer treatment and research</subfield><subfield code="v">57</subfield><subfield code="w">(DE-604)BV000001082</subfield><subfield code="9">57</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005049978&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005049978</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV007693362 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:07:46Z |
| institution | BVB |
| isbn | 0792312120 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005049978 |
| oclc_num | 23287814 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 DE-188 |
| owner_facet | DE-355 DE-BY-UBR DE-12 DE-188 |
| physical | XII, 308 S. Ill., graph. Darst. |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Kluwer |
| record_format | marc |
| series | Cancer treatment and research |
| series2 | Cancer treatment and research |
| spelling | Molecular and clinical advances in anticancer drug resistance ed. by Robert F. Ozols Boston u.a. Kluwer 1991 XII, 308 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer treatment and research 57 Literaturangaben Alkylating Agents pharmacology Doxorubicin pharmacology Drug Resistance genetics Drug resistance in cancer cells Membrane Glycoproteins genetics Neoplasms drug therapy Vinblastine pharmacology Krebszelle (DE-588)4128704-6 gnd rswk-swf Arzneimittelresistenz (DE-588)4143180-7 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Krebs Medizin (DE-588)4073781-0 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Arzneimittelresistenz (DE-588)4143180-7 s Krebszelle (DE-588)4128704-6 s Cytostatikum (DE-588)4068347-3 s Ozols, Robert F. Sonstige oth Cancer treatment and research 57 (DE-604)BV000001082 57 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005049978&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Molecular and clinical advances in anticancer drug resistance Cancer treatment and research Alkylating Agents pharmacology Doxorubicin pharmacology Drug Resistance genetics Drug resistance in cancer cells Membrane Glycoproteins genetics Neoplasms drug therapy Vinblastine pharmacology Krebszelle (DE-588)4128704-6 gnd Arzneimittelresistenz (DE-588)4143180-7 gnd Cytostatikum (DE-588)4068347-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4128704-6 (DE-588)4143180-7 (DE-588)4068347-3 (DE-588)4076066-2 (DE-588)4073781-0 (DE-588)4143413-4 |
| title | Molecular and clinical advances in anticancer drug resistance |
| title_auth | Molecular and clinical advances in anticancer drug resistance |
| title_exact_search | Molecular and clinical advances in anticancer drug resistance |
| title_full | Molecular and clinical advances in anticancer drug resistance ed. by Robert F. Ozols |
| title_fullStr | Molecular and clinical advances in anticancer drug resistance ed. by Robert F. Ozols |
| title_full_unstemmed | Molecular and clinical advances in anticancer drug resistance ed. by Robert F. Ozols |
| title_short | Molecular and clinical advances in anticancer drug resistance |
| title_sort | molecular and clinical advances in anticancer drug resistance |
| topic | Alkylating Agents pharmacology Doxorubicin pharmacology Drug Resistance genetics Drug resistance in cancer cells Membrane Glycoproteins genetics Neoplasms drug therapy Vinblastine pharmacology Krebszelle (DE-588)4128704-6 gnd Arzneimittelresistenz (DE-588)4143180-7 gnd Cytostatikum (DE-588)4068347-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Alkylating Agents pharmacology Doxorubicin pharmacology Drug Resistance genetics Drug resistance in cancer cells Membrane Glycoproteins genetics Neoplasms drug therapy Vinblastine pharmacology Krebszelle Arzneimittelresistenz Cytostatikum Pharmakotherapie Krebs Medizin Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005049978&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000001082 |
| work_keys_str_mv | AT ozolsrobertf molecularandclinicaladvancesinanticancerdrugresistance |